Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neovascular Age-related Macular Degeneration (AMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT07367282
What this trial is testing

Evaluate the Efficacy of Faricimab in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Macular Degeneration
Junyeop Lee 64
Early research (Phase 1)Study completedNCT02022540
What this trial is testing

Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD

Who this might be right for
Age-Related Macular Degeneration (AMD)
PanOptica, Inc. 50
Testing effectiveness (Phase 2)Study completedNCT02462889
What this trial is testing

IAI Versus Sham as Prophylaxis Against Conversion to Neovascular AMD

Who this might be right for
Age-Related Macular Degeneration
Jeffrey S Heier 128
Large-scale testing (Phase 3)Study completedNCT00509795
What this trial is testing

Vascular Endothelial Growth Factor VEGF Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD)

Who this might be right for
Macular Degeneration
Regeneron Pharmaceuticals 1,217
Testing effectiveness (Phase 2)Looking for participantsNCT05986864
What this trial is testing

Phase I/II Study of SKG0106 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration
Skyline Therapeutics (US) Inc. 68
Post-approval studies (Phase 4)Study completedNCT02161575
What this trial is testing

Safety and Efficacy of Switching From Aflibercept to Ranibizumab in Patients With nAMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 103
Not applicableEnded earlyNCT05038371
What this trial is testing

Connective Tissue Growth Factor in Patients With Neovascular Age Related Macular Degeneration

Who this might be right for
Wet Macular Degeneration
Johns Hopkins University 20
Large-scale testing (Phase 3)Study completedNCT05155293
What this trial is testing

Clinical Study to Compare Efficacy and Safety of AVT06 and EU-Eylea (ALVOEYE)

Who this might be right for
Neovascular (Wet) AMD
Alvotech Swiss AG 413
Not applicableUnknownNCT05562336
What this trial is testing

Optical Coherence Tomography Angiography Criteria Of The Choroidal Neovascular Membrane In Wet Age Related Macular Degeneration And In Pathological Myopia (Comparative Study).

Who this might be right for
Choroidal Neovascular Membrane In Wet Age Related Macular Degeneration And In Pathological Myopia
Sohag University 2
Not applicableActive Not RecruitingNCT06439576
What this trial is testing

Real World Evidence in China: Faricimab Use in Diabetic Macular Edema, Retinal Vein Occlusion, and Neovascular Age-Related Macular Degeneration (The Farseeing Study)

Who this might be right for
Diabetic Macular EdemaNeovascular Age-related Macular DegenerationRetinal Vein Occlusion
Hoffmann-La Roche 1,000
Testing effectiveness (Phase 2)Study completedNCT02121353
What this trial is testing

Safety Study of PF582 Versus Lucentis in Patients With Age Related Macular Degeneration

Who this might be right for
Age Related Macular Degeneration (AMD)
Pfenex, Inc 25
Large-scale testing (Phase 3)Study completedNCT00299507
What this trial is testing

Anecortave Acetate in Patients With Exudative Age-related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
Alcon Research 240
Testing effectiveness (Phase 2)Looking for participantsNCT07776522
What this trial is testing

Phase II Study of Subretinal JWK001 for Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD
West China Hospital 50
Large-scale testing (Phase 3)Ended earlyNCT01940900
What this trial is testing

Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy

Who this might be right for
Age-Related Macular Degeneration
Ophthotech Corporation 627
Early research (Phase 1)Study completedNCT00709527
What this trial is testing

ARC1905 (Anti-C5 Aptamer) Given With Lucentis 0.5 mg In People With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Ophthotech Corporation 60
Large-scale testing (Phase 3)Study completedNCT01782989
What this trial is testing

Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)

Who this might be right for
Geographic Atrophy
Paul Yates, MD, PhD 286
Testing effectiveness (Phase 2)Study completedNCT01213082
What this trial is testing

ProspectiveTrial of Proton Beam Combined With Anti-VEGF Therapy for Exudative Age-related Macular Degeneration (AMD)

Who this might be right for
Exudative Age-related Macular Degeneration
University of California, Davis 34
Early research (Phase 1)Active Not RecruitingNCT05698329
What this trial is testing

Effect of AIV007 by Periocular Administration in Subjects with Macular Edema Secondary to Neovascular Age-related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME)

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular EdemaMacular Edema
AiViva BioPharma, Inc. 19
Not applicableActive Not RecruitingNCT04645212
What this trial is testing

Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]

Who this might be right for
Wet Age-related Macular DegenerationNeovascular Age-related Macular Degeneration
Adverum Biotechnologies, Inc. 23
Post-approval studies (Phase 4)UnknownNCT02976194
What this trial is testing

Intraocular Cytokine in Recurrence of Polypoidal Choroidal Vasculopathy

Who this might be right for
Exudative Age-related Macular DegenerationPolypoidal Choroidal Vasculopathy
Pusan National University Hospital 28
Next Page